Navigation Links
New, Larger, Bilateral Breast Graft Kits Announced by MTF
Date:1/4/2012

EDISON, N.J., Jan. 4, 2012 /PRNewswire/ -- The Musculoskeletal Transplant Foundation (MTF) has announced the release of two new sizes of its popular FLEX HD® bi-lateral breast kits. The new sizes--16cm x 20cm and 20cm x 20cm--are being introduced in order to meet the needs of surgeons and their patients. This unique human dermal allograft is specifically prepared and packaged for bilateral breast reconstruction.

It has been a year since MTF introduced its bi-lateral breast kit for the first time.  The new, larger sizes are being released based on surgeon input to accommodate the need for larger tissue coverage that may be called for depending on implant and patient considerations. 

The use of human acellular dermal matrix (ADM) grafts in breast reconstruction is becoming increasingly popular.  Since many breast cases are bilateral, and aesthetic outcomes are desired, surgeons asked MTF for procedure-based kits containing two matched pieces of FlexHD acellular hydrated dermal tissue, prepared from the same donor.

FlexHD grafts offer excellent handling characteristics and biomechanical properties as well as the added benefit of convenience.  They are packaged hydrated and do not require hydration prior to use or refrigeration for storage, resulting in tissue grafts that are easily accessible and ready to use at all times.

FlexHD grafts help to avoid potentially costly and unnecessary work prior to and during cases.  Surgeons may select the size and type of graft they'd like to use any time during a procedure, preventing any of the costs associated with wasted tissue or added OR time.

FlexHD passes USP <71> sterility tests and meets or exceeds FDA and AATB standards for donor criteria, processing and tissue safety. With over 4.8 million grafts distributed since its inception, MTF possesses an unrivaled safety record.

To inquire about these new breast kits contact MTF customer service at 1-800-433-6576.

The Musculoskeletal Transplant Foundation, a non-profit organization, is the nation's leading tissue bank. The Foundation is a national consortium comprised of leading academic medical institutions, organ procurement organizations and tissue recovery organizations.  Since its inception in 1987, MTF has received tissue from close to 90,000 donors and distributed almost five million grafts for transplantation.

For information:
Cindy Gordon, Insight Communication
609.252.1300


'/>"/>
SOURCE The Musculoskeletal Transplant Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bilateral DePuy Hip Implant Failures Lead to Lawsuit
2. Generex Announces Airing of Antigen Express Breast Cancer Vaccine Segment on Bloomberg Television
3. Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment
4. Diablo Valley Oncology Performs Breast Intraoperative Radiation Procedure - First in the East Bay
5. Use of MarginProbe® in DCIS Patients Presented at San Antonio Breast Cancer Symposium
6. Breast Cancer Vaccine Reduces Cancer Recurrence in Women: Interim Results From Phase 2 Clinical Trial Trend Toward AE37 Vaccine Benefit; Results Presented at SABCS
7. Genomic Health Announces Positive Results of First Clinical Outcomes Study for Biomarker Discovery Using Next Generation Sequencing at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
8. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
9. MarginProbe® Pivotal Study Presented at San Antonio Breast Cancer Symposium
10. Survival Benefit With Syndax Pharmaceuticals Entinostat Maintained in Women with Advanced Breast Cancer
11. Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... MAITLAND, Fla. , May 22, 2017 /PRNewswire/ ... industry as a whole continue to make the ... evidence becomes increasingly important for ensuring positive patient ... Key industry stakeholders are shifting focus away from ... results and effects of long-term specialty drug therapy ...
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based ... to treat Parkinson,s disease (PD), has enrolled the first patient ... randomized, controlled, multicenter study involving patients with PD and taking ... over a 9-to-12-month period. The first stage is open label ... Participating sites include Denver , ...
(Date:5/10/2017)... -- Global Health Intelligence (GHI), the leading healthcare ... published its 2017 ranking of the Best-Equipped Hospitals in ... analysis from GHI,s hospitals database for Latin America , ... The GHI database covers 86% of the hospitals in ... points for each institution in key areas such as beds, ...
Breaking Medicine Technology:
(Date:5/24/2017)... , ... May 24, 2017 , ... Patients who want ... OH, can now meet with Dr. Joseph Bedich for a consultation, with or without ... improving their oral health and functionality. , Dr. Bedich offers a variety ...
(Date:5/24/2017)... , ... May 24, 2017 ... ... the female reproductive tract in which the endometrial lining of the uterus ... inflammation and pain. Patients experiencing painful intercourse, painful periods, pelvic pain, or ...
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... practice is offering holistic pediatric dentistry options for its patients on Long Island, ... the patient’s entire physical well being, and is one of the biggest trends ...
(Date:5/24/2017)... Orange, NJ (PRWEB) , ... May 24, 2017 , ... ... for avoiding back injury when either lifting weights for strength training and exercise or ... Atlantic Spine Center . , “Body position is everything,” Dr. Chang says. “Improper technique ...
(Date:5/23/2017)... ... ... Allegheny Health Network and the Alexis Joy D’Achille Foundation ... at West Penn Hospital , a unique facility that will offer the most ... Construction of the Center is underway with a scheduled opening in the fall of ...
Breaking Medicine News(10 mins):